OTC Recalls Aside, J&J Says Business Still Burdened By Economic Factors

摘要

Johnson & Johnson concedes that even without the fallout from a recent string of OTC drug recalls, its consumer healthcare business would have been "flat to slightly down" for the quarter. The firm continues to struggle with external factors - private-label competition among them, according to VP of Finance and CFO Dominic Caruso.